Why the study?
Does norepinephrine plus dobutamine reduce 28-day mortality in patients with septic shock compared to other vasoactive medications?
Population
Patients with septic shock
Comparison
Norepinephrine plus dobutamine vs Other vasoactive medications
Design
Meta-analysis
Follow-up
28 days
Authors
Loading...
May support norepinephrine-dobutamine in low-output septic shock; leaves open need for confirmatory RCTs.
Does norepinephrine plus dobutamine reduce 28-day mortality in patients with septic shock compared to other vasoactive medications?
Norepinephrine combined with dobutamine may improve 28-day survival in patients with septic shock, particularly those with low cardiac output.
Cheng et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: